These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9168497)

  • 1. [Non-surgical therapy for ulcerative colitis].
    Asakura H; Suzuki K; Honma T
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):431-7. PubMed ID: 9168497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
    Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
    J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ulcerative colitis and intestinal bleeding].
    Asakura H
    Nihon Rinsho; 1998 Sep; 56(9):2354-9. PubMed ID: 9780719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
    Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
    Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
    Andoh A; Ogawa A; Kitamura K; Inatomi O; Fujino S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y
    J Gastroenterol; 2004 Dec; 39(12):1150-7. PubMed ID: 15622478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease: short- and long-term treatments.
    Bickston SJ; Cominelli F
    Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
    [No Abstract]   [Full Text] [Related]  

  • 7. Ulcerative colitis: pathogenesis, diagnosis, and current treatment.
    Griffel LH; Das KM
    J Assoc Acad Minor Phys; 1996; 7(3):63-9. PubMed ID: 8803417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute severe ulcerative colitis: timing is everything.
    Gulliford SR; Limdi JK
    Postgrad Med J; 2011 Mar; 87(1025):215-22. PubMed ID: 21242575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flare up of ulcerative colitis during pregnancy treated by adsorptive granulocyte and monocyte apheresis: therapeutic outcomes in three pregnant patients.
    Takahashi H; Sugawara K; Sugimura M; Iwabuchi M; Mano Y; Ukai K; Tadokoro K
    Arch Gynecol Obstet; 2013 Aug; 288(2):341-7. PubMed ID: 23404436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T; Inoue N; Ogata H; Naganuma M
    J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytapheresis in the treatment of patients with active ulcerative colitis.
    Bresci G
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):639-43. PubMed ID: 19072341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
    Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of leukocytapheresis-induced changes in gene expression patterns of peripheral blood mononuclear cells in patients with ulcerative colitis.
    Yagi Y; Andoh A; Ogawa A; Bamba S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2007 Oct; 11(5):331-6. PubMed ID: 17845392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic therapy of Crohn's disease and ulcerative colitis].
    Banai J
    Orv Hetil; 2000 May; 141(22):1171-7. PubMed ID: 10853345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of acute severe ulcerative colitis.
    Doherty GA; Cheifetz AS
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathology of ulcerative colitis and the non-invasive therapy].
    Asakura H
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1480-5. PubMed ID: 8245649
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    Dig Liver Dis; 2007 May; 39(5):430-4. PubMed ID: 17379588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
    Jo Y; Matsumoto T; Mibu R; Iida M
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.